SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : DOSE(capstone pharm) -- Ignore unavailable to you. Want to Upgrade?


To: Rob Anderson who wrote (82)8/28/1998 11:13:00 AM
From: Rob Anderson  Read Replies (1) | Respond to of 92
 
Time to buy DOSE continues to expand thro acquisition! With a PE below 7 trading at $4.00 earnings .63. Book value is $6.17.

This is an awsome buying opportunity!




To: Rob Anderson who wrote (82)9/3/1998 9:52:00 PM
From: LLCF  Read Replies (1) | Respond to of 92
 
<Any idea how the recent news on the 2008 notes will affect the stock price?>

What news is that?

DAK